Whitni Davidson

Whitni Davidson

Auto-generated profile, based on publicly available information

Whitni Davidson

Poxvirus and Rabies Branch, Centers for Disease Control and Prevention , Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2022 in Science
Verified
Journal Article
Closed access
CGCrystal M. Gigante
Crystal M. Gigante
BKBette Tina Marie Korber
Bette Tina Marie Korber
MSMatthew Hunter Seabolt
Matthew Hunter Seabolt
KWKimberly Wilkins
Kimberly Wilkins
WDWhitni Davidson
Whitni Davidson
YLYu Li
Yu Li
Monkeypox is a viral zoonotic disease endemic in Central and West Africa. In May 2022, dozens of non-endemic countries reported hundreds of monkeypox cases, most with no epidemiological link to Africa. We identified two lineages of monkeypox virus (MPXV) among two 2021 and seven 2022 US monkeypox cases: the major 2022 outbreak variant called B.1 and a minor contemporaneously sampled variant called A.2. Analyses of mutations among these two variants revealed an extreme preference for GA-to-AA mutations indicative of human APOBEC3 cytosine deaminase activity among Clade IIb MPXV (previously West African, Nigeria) sampled since 2017. Such mutations were not enriched within other MPXV clades. These findings suggest that APOBEC3 editing may be a recurrent and a dominant driver of MPXV evolution within the current outbreak.

25 October 2019 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
EWErin R. Whitehouse
Erin R. Whitehouse
ARAgam K. Rao
Agam K. Rao
YYYon C. Yu
Yon C. Yu
PYPatricia A. Yu
Patricia A. Yu
MGMargaret Griffin
Margaret Griffin
BPBrett W. Petersen
Brett W. Petersen
An unvaccinated laboratory worker with a needlestick exposure to vaccinia virus developed a lesion on her left index finger.

8 September 2025 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
EMEric Q Mooring
Eric Q Mooring
JRJulia Rogers
Julia Rogers
FWFlorence Whitehill
Florence Whitehill
ZWZachary Werle
Zachary Werle
CGCrystal M. Gigante
Crystal M. Gigante
JMJoseph B McLaughlin
Joseph B McLaughlin
Background: Borealpox virus (previously known as Alaskapox virus) is an Orthopoxvirus species first identified in a patient living near Fairbanks, Alaska, in 2015; the source of the patient's infection was unknown. Six additional borealpox cases have been identified through 2023. Methods: We conducted interviews to ascertain travel history and potential exposures for the six patients, trapped small mammals for orthopoxvirus testing, and performed a phylogenetic analysis of viral DNA sequences. Results: Five patients had similar clinical illness, consisting of at least one lesion and, in most cases, lymphadenopathy. One patient with underlying immunosuppression experienced severe illness, hospitalization, and died despite receiving investigational orthopoxvirus therapeutics. One of the patients had a self-reported prior history of smallpox vaccination. None had traveled outside of Alaska, and there was no evidence of person-to-person transmission. Borealpox virus DNA and serologic evidence for past orthopoxvirus infection were detected in multiple small-mammal species. Genetic distance and phylogenetic analyses are compatible with multiple spillover events from animals to humans. Conclusions: Epidemiologic, ecologic, and phylogenetic evidence indicate that borealpox is a zoonotic disease, and current data suggest the reservoir is likely small mammals. Although most infections are mild and self-limiting, immunosuppressed persons may be at risk for severe disease. Further studies are needed to determine the geographic range of borealpox virus in small mammals throughout the Circumpolar North.